Aflac price target raised to $107 from $105 at Wells Fargo

Wells Fargo raised the firm’s price target on Aflac (AFL) to $107 from $105 and keeps an Equal Weight rating on the shares. The firm updated the company’s model post the Q2 report. Aflac posted a strong quarter with a rebound in sales driven by the roll-out of its new cancer product, the analyst tells investors in a research note.